About Recipharm Holding India Private Limited
Data last updated:
Recipharm Holding India Private Limited was a foreign private limited company based in Mumbai, Maharashtra, India, operated as a subsidiary of Recipharm Participation Bv. The company has been amalgamated - it was merged with another entity and no longer exists as a separate legal entity. It operated in the financial holding companies segment of the financial services sector. It was incorporated on 15 March 2016.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2016FTC440048.
The company had an authorised share capital of ₹48.1 Cr and a paid-up capital of ₹43.72 Cr. It was led by directors including Suresh Nagappa Ganachari and Emmanuel Nicolas Grand.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office was at Mumbai, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹437.02 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net loss of ₹729.06 Cr (net margin -166.8%) and EBITDA of -₹672.85 Cr (EBITDA margin -154%). Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 7% over five years.
The company was associated with 1 brand: Recipharm. Court records list 1 case involving the company, including 1 filed by the company. The company has 5 deals on record (4 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹1,624.89 Cr; the latest was in December 2023. Its 10 peer companies in the BFSI industry (Holding Company) are compared by revenue, 5 larger and 5 smaller; the largest is BT Telecom India Private Limited with revenue of ₹484.56 Cr.
The last known website on record is recipharm.com.
Company details
CIN history
Recipharm Holding India has one previous CIN (Corporate Identification Number): U74999HP2016FTC001175. The current CIN is U74999MH2016FTC440048, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74999MH2016FTC440048 | Current |
| U74999HP2016FTC001175 | Previous |
Contact details
Recipharm Holding India Private Limited's registered office is in Mumbai, Maharashtra.
- Social Media
- Registered AddressFlat No. 502 B Wing Building No. 48, Tilak Indrayani Housing Society Tilak Nagar (W) Chembur, Mumbai, Maharashtra, India – 400089
- IndustryFinancial Services, Financial Holding Companies
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Recipharm Holding India operates one associated brand: Recipharm. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical development and manufacturing services are offered contractually. | recipharm.com |
Financials of Recipharm Holding India Private Limited
FY 2024 filings availableRecipharm Holding India Private Limited reported revenue of ₹437.02 Cr (down 25% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 25% fall in the latest year. EBITDA fell 803% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹672.85 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹729.06 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -154% | ||||
| Net Profit Margin | -166.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Recipharm Holding India Private Limited, buy the company report.
Board of directors of Recipharm Holding India Private Limited
Recipharm Holding India has 3 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Suresh Nagappa Ganachari | Director | 28 Nov 2022 | 3 Years 11 Months | As last reported |
| Emmanuel Nicolas Grand | Director | 06 Jan 2023 | 3 Years 10 Months | As last reported |
| Daniela Schalko | Additional Director | 28 Jan 2025 | 1 Years 9 Months | As last reported |
Peer comparison
Recipharm Holding India Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Holding Company), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BT Telecom India Private Limited | ₹484.56 Cr (FY 2025) | -6.0% | New Delhi, Delhi, India | |||
| Composure Services Private Limited | ₹473.25 Cr (FY 2021) | -11.0% | Kolkata, West Bengal, India | |||
| Espire Conglomerate Private Limited | ₹473.02 Cr (FY 2023) | 56.0% | New Delhi, Delhi, India | |||
| Opg Holdings India Private Limited | ₹468.88 Cr (FY 2025) | 69.0% | Bangalore, Karnataka, India | |||
| Lotus Retail Private Limited | ₹453.3 Cr (FY 2025) | -3.0% | Jaipur, Rajasthan, India | |||
| Recipharm Holding India Private Limitedthis company | ₹437.02 Cr (FY 2024) | -₹729.06 Cr | -166.8% | -25.0% | Mumbai, Maharashtra, India | |
| BNP Paribas India Holding Private Limited | ₹436.51 Cr (FY 2024) | 110.0% | Mumbai, Maharashtra, India | |||
| Sarg Media Holding Private Limited | ₹429.18 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Pil Industries Limited | ₹421.57 Cr (FY 2016) | 2.0% | W.E.F.01/11/2003, Maharashtra, India | |||
| Manipur State Power Company Limited | ₹395.8 Cr (FY 2015) | Imphal, Manipur, India | ||||
| Lupin Investments Private Limited | ₹376.18 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Recipharm Holding India Private Limited, buy the company report.
Deals & funding
Recipharm Holding India Private Limited has 5 deals on record (4 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹1,624.89 Cr; the latest was in December 2023.
Deals on record (1 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2023 | Secondary share transfer | Undisclosed | Seller: an individual |
To see the full deal history of Recipharm Holding India Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Recipharm Holding India Private Limited has 1 court case on record: 1 filed by Recipharm Holding India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| NCLT | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| NCLT, Chandigarh | Court case (C.P.(CAA)) | Filed by the company | Disposed |
To see the full case history of Recipharm Holding India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Recipharm Holding India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Recipharm Holding India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Recipharm Holding India Private Limited has 10 board changes on record since 2017: 3 appointments and 7 cessations. The latest: Daniela Schalko was appointed as Additional Director on 28 Jan 2025.
1 earlier event is in the company report.
News
Frequently asked questions
Recipharm Holding India has been "Amalgamated" (merged) as per MCA records. The company was combined with another entity and no longer exists as a separate legal entity. Business activities, if any, continue under the successor entity.
Recipharm Holding India was a foreign private limited company based in Mumbai, Maharashtra, India. The company worked in financial holding companies, within the financial services industry. It was incorporated on 15 March 2016 and is registered under CIN U74999MH2016FTC440048. The company is recorded as amalgamated in MCA records and no longer exists as a legal entity.
Recipharm Holding India was incorporated on 15 March 2016. It is registered with the Registrar of Companies, Mumbai.
Recipharm Holding India had 3 directors:
- Suresh Nagappa Ganachari - Director
- Emmanuel Nicolas Grand - Director
- Daniela Schalko - Additional Director
The CIN (Corporate Identification Number) of Recipharm Holding India is U74999MH2016FTC440048. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Recipharm Holding India is at Flat No. 502 B Wing Building No. 48, Tilak Indrayani Housing Society Tilak Nagar W Chembur, Mumbai, Maharashtra, India – 400089.
Recipharm Holding India can be reached through the website recipharm.com. Its registered office is in Mumbai, Maharashtra, India.
The latest financial statements of Recipharm Holding India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
Recipharm Holding India operated in the financial services industry, in the financial holding companies segment.
Recipharm Holding India has 5 deals on record (4 convertible or debt financings, 1 secondary share transfer), with disclosed funding of ₹1,624.89 Cr; the latest was in December 2023.
The peers of Recipharm Holding India by revenue are BT Telecom India Private Limited, Composure Services Private Limited, Espire Conglomerate Private Limited, Opg Holdings India Private Limited, Lotus Retail Private Limited and 5 more, all in the BFSI industry (Holding Company).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
